Home | Clinical | New Drugs Online
NDO Logo

Home | Additional information is available to accredited, [registered, NHS users]

New Drugs Online Report for remacemide
Generic Name:
Trade Name:  
Synonym: PR 934423 
Entry Type: New molecular entity  
Development and Regulatory status
UK: Discontinued 
EU: Discontinued 
US: Discontinued 
UK launch Plans: Available only to registered users
Actual UK launch date:  
Trial or other data
US filing for epilepsy expected 2001. Also C2 for neuroprotection in coronary artery bypass surgery, treatment of stroke and Huntington's disease. US filing for Parkinson's Dis. is expected in 2002. 
Available only to registered users
BNF Category:
Central nervous system (04)
Pharmacology: Non-competitive NMDA antagonist  
Indication: Epilepsy 
Company Information
Name: AstraZeneca 
US Name: AstraZeneca 
Further Information
Anticipated commissioning route (England)
High cost drug list? Awaiting Update
Implications Available only to registered users